-
Regulator halts import of GSK’s asthma drug and imposes a fine
30 Jul 2024 04:26 GMT
… Seretide 500 Discus, and Flixotide Junior Evohaler 50 mcg (fluticasone … all of which are specialty medications used to treat asthma.
… on the Safety of Pharmaceuticals and Other Drugs.
In addition, in … the case of GSK's acne treatment …
-
South Korea regulator hits GSK for problems with asthma, acne drugs: report
30 Jul 2024 14:08 GMT
… on certain asthma and acne treatments, Korea Biomedical Review reports … and Flixotide Junior Evohaler 50, according to KBR. The drugs are … its labels for acne drug Duacgel 5% (clindamycin phosphate … month import suspension on Flixotide Junior Evohaler 50mcg that …
-
New asthma medicine restrictions will hurt the poorest children the most
12 Apr 2023 09:11 GMT
… by the brand names Flixotide Junior or Axotide Junior. … the safest and most effective treatments. In fact, the World … and efficacy of the medicine.
The Pharmaceutical Benefits Scheme (PBS) … new rules
Previously, any doctor could prescribe low dose fluticasone …
-
Pharmaceutical aerosols ─ uses and advantages
03 Jan 2019 10:05 GMT
… offers further potential for systemic drug delivery.
MDIs
The MDI is … steroid such as Fluticasone/Flixotide (orange), Seretide (purple), Becotide… inhaled pharmaceutical aerosols is growing rapidly due to the inhaled medications for treatment …
-
Respiratory Drugs: Consumption, Demand, Sales, Competitor and Forecast 2016 – 2021
13 Oct 2016 12:32 GMT
… a combination of drugs from several treatment categories, including mucolytic … products?
Respiratory disorders clinical trials have an overall attrition … in terms of clinical trial failure rate?
The respiratory … Co. 43
3.6 Flixotide/Flovent - GSK …
-
Ways to prevent flare-ups of asthma highlighted
20 Jun 2023 17:00 GMT
… pump for asthma treatment could speak to their doctor or Open Airways … treatment would be to use a preventer, such as Becotide or Flixotide … education on asthma or COPD, medication, their uses, demonstration of best …
-
Circassia Announces Duaklir(R) Successfully Met Primary Endpoints in AMPLIFY Phase III Study in Chronic Obstructive Pulmonary Disease
07 Sep 2017 06:18 GMT
… CIR), a specialty pharmaceutical company focused on respiratory … States Food and Drug Administration (FDA) during the first … quot;
Steve Lewington, Global Medicine Leader, Respiratory, AstraZeneca … asthma treatment targets substitution of GSK's Flixotide® …